Filing Flows › Viatris (VTRS) › Lipitor revenue
Viatris (VTRS) Lipitor revenue by quarter
Viatris' Lipitor revenue was $452M in Q3 2026 (third quarter 2026), -0.1% from Q2 2026. Over the last 6 quarters it ranged from $388M (Q2 2025) to $462M (Q1 2026).
| Quarter | Lipitor revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $452M | -0.1% | +14% |
| Q2 2026 | $452M | -2% | +17% |
| Q1 2026 | $462M | +17% | +19% |
| Q3 2025 | $396M | +2% | — |
| Q2 2025 | $388M | 0% | — |
| Q1 2025 | $388M | — | — |
Q3 2026 at a glance
Viatris, Q3 2026: revenue $3.7B (-0.3% year over year), operating margin 7.0%, net loss $325M, operating cash flow $899M. The chart follows the revenue to costs, profit and cash.
Questions
What is Viatris' Lipitor revenue?
Viatris' Lipitor revenue was $452M in Q3 2026 (third quarter 2026), -0.1% from Q2 2026.
How has Viatris' Lipitor revenue changed?
Over the last 6 quarters it ranged from $388M (Q2 2025) to $462M (Q1 2026).